The PCYOX1 Polyclonal Antibody (PACO11120) is an essential tool for researchers studying PCYOX1, a protein involved in oxidative stress response and lipid metabolism. This antibody, raised in rabbits, shows high specificity and sensitivity for detecting PCYOX1 in human samples, making it ideal for Western blot applications. By binding to PCYOX1, this antibody enables precise detection and analysis in a variety of cell types, providing valuable insights for studies in biochemistry, metabolism, and cellular signaling pathways.PCYOX1, also known as Peroxisomal NADH-cytochrome b5 reductase-like protein, plays a critical role in regulating cellular redox balance and lipid metabolism.
Dysfunction in PCYOX1 has been implicated in various diseases, including metabolic disorders and cardiovascular diseases. Therefore, understanding the function and regulation of PCYOX1 is crucial for developing targeted therapies and interventions for these conditions.Overall, the PACO11120 Polyclonal Antibody offers researchers a reliable tool for investigating the role of PCYOX1 in cellular physiology and disease pathways, paving the way for advancements in precision medicine and personalized healthcare.
Prenylcysteine is released during the degradation of prenylated proteins. PCYOX1 catalyzes the degradation of prenylcysteine to yield free cysteines and a hydrophobic isoprenoid product (Tschantz et al., 1999 [PubMed 10585463]).[supplied by OMIM, Mar 2008]
